Archived NHGRI record
2018 State Bills Massachusetts 2018 H.4639
Massachusetts
- Status
- Died
- Database
- NHGRI archive
- Source database updated
- February 8, 2024
- Snapshot retrieved
- September 1, 2026
Summary
Measure to enhance high quality, affordable health care. The bill includes a provision requiring coverage for genetically targeted drugs for Duchenne muscular dystrophy, if offered to active or retired employees of the commonwealth insured under the group insurance commission. Died.
Record details
Archived source metadata
Source links
Archive details
Courtesy: National Human Genome Research Institute. This archive preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.
Report a source problem
Report a transcription problem, changed legal status, or newer official source for human review. Any correction remains separate from the archived NHGRI wording.
Cite this archived record
NHGRI Genome Statute and Legislation Database. 2018 State Bills Massachusetts 2018 H.4639. Archived by Who Owns Your DNA? Retrieved September 1, 2026. https://whoownsyourdna.org/source-records/nhgri/nhgri-78f5248fdb278586293d/